Chemoradiotherapy for Head and Neck Cancer

By I. D’Onofrio, V. Nardone, Alfonso Reginelli, S. Cappabianca. 2023

Subfields: Oncology, Otorhinolaryngology

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. M. Knebel
2. Maximilian Linxweiler
3. S. Körner
4. L. Brust
5. Matthias Schneider
6. F. Braun
7. S. Wemmert
8. J. Kühn

Citations in the corpus

• Expression of 3q Oncogene SEC62 Predicts Survival in Head and Neck Squamous Cell Carcinoma Patients Treated with Primary Chemoradiation (2023, background): “However, the response to therapy is highly heterogeneous [5] with only a few established predictive biomarkers, including tumor human papillomavirus (HPV) status [13–15], tobacco consumption [13,15], tumor stage [13], nodal stage [13], and tumor hypoxia [16].”